SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089982
Filing Date
2023-11-27
Accepted
2023-11-27 08:30:09
Documents
13
Period of Report
2023-11-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189026-8k_bimiinter.htm   iXBRL 8-K 27294
2 PRESS RELEASE DATED NOVEMBER 22, 2023 ea189026ex99-1_bimiinter.htm EX-99.1 6149
  Complete submission text file 0001213900-23-089982.txt   209812

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20231122.xsd EX-101.SCH 3009
4 XBRL LABEL FILE bimi-20231122_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bimi-20231122_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea189026-8k_bimiinter_htm.xml XML 3411
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 231437360
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries